<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the patient with visual hallucinations</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the patient with visual hallucinations</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the patient with visual hallucinations</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Victoria S Pelak, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul W Brazis, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 29, 2019.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Visual hallucinations are a clinical manifestation of neuroophthalmologic dysfunction resulting from a wide variety of underlying etiologies. They can be very disconcerting to some patients, regardless of their insight, and can significantly decrease quality of life [<a href="#rid1">1</a>].</p><p>Familiarity with the disorders associated with visual hallucinations is essential to provide the appropriate care. The history, accompanying symptoms, and clinical signs are important elements for determining the most likely cause. In certain patients, further investigation may be necessary before a definitive cause can be determined.</p><p>This topic discusses the most common causes of visual hallucinations and their distinguishing features. Visual hallucinations associated with the Charles Bonnet syndrome (CBS) are discussed separately. (See  <a class="medical medical_review" href="/d/html/5250.html" rel="external">"Visual release hallucinations (Charles Bonnet syndrome)"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">CLASSIFICATION AND TERMINOLOGY</span><span class="headingEndMark"> — </span>A visual hallucination is a perception of an external visual stimulus where none exists. By contrast, a visual illusion is a distortion or modification of real external visual stimuli [<a href="#rid2">2</a>]. Examples of visual illusions include distortions of size (micropsia or macropsia), shape (metamorphopsia), and color (dyschromatopsia). Visual hallucinations and illusions are clinically distinct phenomena, but have overlapping etiologies.</p><p>A useful classification scheme categorizes hallucinations as simple or complex [<a href="#rid3">3</a>]. Classifying the hallucination as simple or complex can narrow the differential diagnosis for the underlying cause.</p><p class="bulletIndent1"><span class="glyph">●</span>Simple hallucinations are also referred to as "elementary" or "non-formed." They do not include complex imagery. Examples include lights, colors, lines, shapes, or geometric designs. Simple hallucinations of light can be further classified as phosphenes, which are visual hallucinations of lights without structure, and photopsias, which are visual hallucinations of lights with geometric-like structure (triangles, diamonds, squares).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complex hallucinations can include images of people, animals, objects, or a lifelike scene. Complex hallucinations are also referred to as "formed."</p><p></p><p>Another classification scheme divides visual hallucinations into irritative phenomena that result in brief stereotyped hallucinations, and release hallucinations that are continuous and variable [<a href="#rid4">4</a>]. This classification scheme is somewhat limited because the generalizations are not absolute, and some disorders have characteristics of both types. As an example, in migraine, visual hallucinations can be stereotyped and brief, or variable and continuous. Hallucinations associated with peduncular hallucinosis are often brief, but the content tends to be variable and not stereotyped.</p><p class="headingAnchor" id="H4"><span class="h1">ETIOLOGIES</span><span class="headingEndMark"> — </span>The clinical features of various causes of visual hallucinations are summarized in the table and are discussed below  (<a class="graphic graphic_table graphicRef73106" href="/d/graphic/73106.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H5"><span class="h2">Retinal pathology</span><span class="headingEndMark"> — </span>Traction, irritation, injury, or disease of the retina can stimulate retinal photoreceptors, causing simple hallucinations in the form of flashes, sparks, or streaks of light.</p><p>A posterior vitreous detachment (PVD) producing traction on the retina is a common cause of retinal hallucinations, particularly in older patients [<a href="#rid5">5</a>]. Other potential retinal causes are listed in the table  (<a class="graphic graphic_table graphicRef82416" href="/d/graphic/82416.html" rel="external">table 2</a>).</p><p>Hallucinations associated with retinal pathology are never complex. Insight is intact. Intrinsic motion is a common feature of the hallucinations of light; patients often describe flashes or flashing, whirls, shooting, lightning-like, or spinning pinwheels. In many cases, the condition and the hallucinations are monocular, but some conditions (eg, cancer-associated retinopathy) can affect both retinas concomitantly, producing binocular hallucinations. The hallucination can occur in any area of the visual field. In cases of retinal traction, Valsalva-like maneuvers may be a trigger.</p><p>The duration of the hallucination is usually measured in seconds. The frequency is variable. While some patients experience multiple, brief hallucinations with waxing and waning frequency throughout the day, others may experience only one to three events prior to presentation. More frequent or persistent retinal hallucinations are associated with certain types of acute zonal occult outer retinopathy (AZOOR) and with cancer-associated retinopathies [<a href="#rid6">6,7</a>]. By contrast, patients with PVD are likely to present with only a few episodes.</p><p>If a scotoma (a circumscribed area of decreased vision) develops after the onset of simple hallucinations, this can indicate a retinal injury that may become permanent if not evaluated and treated promptly (eg, retinal detachment). In addition to vision loss, the symptoms of retinal injury include seeing shadows or having distorted, warped, or blurred vision.</p><p>All hallucinations suspected to be of retinal origin should prompt an urgent evaluation by an ophthalmologist to ensure that the retina is intact (ie, no tears, holes, detachments). If the retinal examination is normal, but other signs and symptoms suggest retinal disease, then occult retinal disorders such as cancer-associated retinopathy or certain types of AZOOR could be responsible. A formal visual field test, electroretinogram, and serum studies for antibodies against retinal proteins (eg, recoverin or enolase) may be useful in revealing a cause of retinal dysfunction [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/d/html/15837.html" rel="external">"Paraneoplastic visual syndromes"</a>.) </p><p class="headingAnchor" id="H6"><span class="h2">Vision loss (release hallucinations or Charles Bonnet syndrome)</span><span class="headingEndMark"> — </span>Visual acuity loss or visual field loss from any cause, affecting the eye, optic nerve, chiasm, or tract, optic radiations, or the visual cortex, can cause visual hallucinations, often referred to as release hallucinations or Charles Bonnet syndrome (CBS) [<a href="#rid9">9</a>].</p><p>CBS is most often reported in older adult patients, reflecting the mean age of the most common underlying conditions: age-related macular degeneration, glaucoma, diabetic retinopathy, and cerebral infarction [<a href="#rid9">9-14</a>]. Cognitive impairment and social deprivation may be risk factors [<a href="#rid12">12,15-19</a>].</p><p>These visual hallucinations can be simple or complex. Features that help distinguish CBS from psychosis are the absence of auditory or somatosensory hallucinations and other abnormal thought content [<a href="#rid13">13</a>]. Because the hallucinations tend to occur in the area of vision loss, they can be monocular or binocular and/or restricted to one segment of the visual field. Most patients report a duration of several minutes, but they can last less than one minute or be continuous [<a href="#rid1">1,9,14,16,20</a>]. While the majority of patients experience hallucinations multiple times a day or week, some patients experience only a few isolated episodes [<a href="#rid1">1,11,14</a>]. Insight is usually retained.</p><p>Patients without known ocular disease require an ophthalmologic and/or neurologic evaluation to determine the underlying cause of vision loss. CBS is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5250.html" rel="external">"Visual release hallucinations (Charles Bonnet syndrome)"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Migraine aura</span><span class="headingEndMark"> — </span>Approximately 15 percent of individuals with migraine experience aura. Visual aura is the most common type of aura, occurring in 90 percent of people with migraine aura [<a href="#rid21">21-23</a>]. Most studies estimate the lifetime prevalence of visual aura of migraine to be between 0.7 to 1.2 percent [<a href="#rid24">24-26</a>].</p><p>The pathophysiology of migraine aura is not well understood, but is believed to be related to a phenomenon known as cortical spreading depression, a self-propagating wave of neuronal and glial depolarization that spreads across the cerebral cortex [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Pathophysiology'</a>.)</p><p class="headingAnchor" id="H2559114428"><span class="h3">Clinical features</span><span class="headingEndMark"> — </span>Migrainous visual hallucinations are usually simple and typically linear or geometric (eg, zig-zag lines) in appearance [<a href="#rid28">28</a>]. The classic visual aura is the fortification spectra, which is considered pathognomonic for migraine  (<a class="graphic graphic_figure graphicRef59061" href="/d/graphic/59061.html" rel="external">figure 1</a>). A scintillating scotoma is another common migraine aura; this is an area of decreased vision that is outlined by a hallucination with geometric design. Patients also describe seeing spots, dots, or shooting stars. Migraine auras tend to be black and white or monochromatic, and are more geometric and linear in shape compared with epileptic visual hallucinations, which are more often colorful and circular or spherical in appearance [<a href="#rid28">28,29</a>].</p><p>Migraine aura can also include vision loss and visual distortions, such as the appearance of heat waves and tunnel vision. Objects may appear smaller or larger (micropsia and macropsia) or with distorted contours [<a href="#rid30">30,31</a>]. Complex visual hallucinations are uncommon, but have been described in migraine [<a href="#rid30">30,32</a>]. Patients with migrainous visual hallucinations retain insight, almost without exception.</p><p>All migraine hallucinations are believed to be binocular. It is unclear if monocular visual hallucinations of migraine truly exist [<a href="#rid33">33</a>]. However, many patients report monocular symptoms, likely misinterpreting binocular, homonymous visual field hallucinations as occurring only in the ipsilateral eye.</p><p>Migrainous visual hallucinations can occur in any area of the visual field, but commonly begin in the central portion [<a href="#rid28">28</a>]. Growth or spread of the aura, often from the center to the periphery of the visual field, occurring over a few minutes is a common feature of migraine that helps distinguish it from seizure (in which spread occurs more rapidly, over a few seconds) and retinal hallucinations (which do not tend to grow or spread) [<a href="#rid28">28,30,31,34</a>]. A minority of migrainous visual auras are abrupt in onset.</p><p>The usual duration for migraine aura is between 4 and 60 minutes, contrasting with the usually much briefer duration of retinal or epileptic hallucinations [<a href="#rid28">28,30,34,35</a>]. More prolonged migrainous visual auras are less common; however, some case series have described patients with persistent visual aura of migraine that lasts months or longer [<a href="#rid36">36-39</a>].</p><p>The frequency of migraine aura is highly variable. It is rare for these to occur multiple times a day. Some patients experience only one episode in a lifetime.</p><p class="headingAnchor" id="H3383728417"><span class="h3">Associated symptoms</span><span class="headingEndMark"> — </span>Common associated symptoms include headache and other features of migraine: nausea, vomiting, photophobia, and phonophobia. These follow the aura in most patients [<a href="#rid28">28</a>]. Headache is neither sensitive nor specific for migraine as it is also a common postictal feature of occipital epilepsy [<a href="#rid40">40</a>]. Also, isolated visual hallucinations without headache that are presumed to be of migraine origin are common; these are often called acephalgic migraine, migraine accompaniments, or migraine aura without headache [<a href="#rid28">28</a>]. Up to one-third of patients with visual migraine aura experience other aura symptoms such as motor and sensory deficits or aphasia [<a href="#rid28">28,34</a>]. (See  <a class="medical medical_review" href="/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"</a>.)</p><p class="headingAnchor" id="H2675679990"><span class="h3">Diagnosis</span><span class="headingEndMark"> — </span>There is no diagnostic test that confirms a migraine diagnosis, which is based on clinical features and sometimes the exclusion of other causes (see <a class="local">'Evaluation'</a> below). In one study, a rating scale of five clinical features (duration of 5 to 60 minutes, gradual onset over 5 minutes or more, scotoma, zig-zag lines, and visual field lateralization) distinguished 362 patients with migraine aura from 108 patients with other forms of visual disturbance with a sensitivity and specificity of 91 and 96 percent, respectively [<a href="#rid41">41</a>].</p><p>The International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria for migraine aura require at least two attacks of aura with fully reversible symptoms, of either visual, sensory, motor, brainstem, or speech disturbance, with at least three of the following features [<a href="#rid42">42</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At least one aura symptom spreads gradually over ≥5 minutes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more symptoms occur in succession</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Each individual aura symptom lasts 5 to 60 minutes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At least one aura symptom is unilateral</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At least one aura symptom is positive</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The aura is accompanied, or followed within 60 minutes, by headache</p><p></p><p>(See  <a class="medical medical_review" href="/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Diagnostic criteria'</a>.)</p><p class="headingAnchor" id="H699659606"><span class="h3">Treatment</span><span class="headingEndMark"> — </span>Treatment of migraine headache with aura is discussed separately (see  <a class="medical medical_review" href="/d/html/3345.html" rel="external">"Preventive treatment of episodic migraine in adults"</a> and  <a class="medical medical_review" href="/d/html/3347.html" rel="external">"Acute treatment of migraine in adults"</a>). Treatments for visual aura without headache and persistent visual aura of migraine have not been well studied. In the author's experience, <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a> may be useful as a prophylactic treatment for migraine visual aura without headache. In case reports, agents with efficacy for persistent visual aura include <a class="drug drug_general" data-topicid="9268" href="/d/drug information/9268.html" rel="external">acetazolamide</a>, <a class="drug drug_general" data-topicid="9702" href="/d/drug information/9702.html" rel="external">nimodipine</a>, <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a>, <a class="drug drug_general" data-topicid="9545" href="/d/drug information/9545.html" rel="external">lamotrigine</a>, and <a class="drug drug_general" data-topicid="10035" href="/d/drug information/10035.html" rel="external">valproate</a> [<a href="#rid37">37,39,43-45</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Seizures</span><span class="headingEndMark"> — </span>Visual hallucinations of epileptic origin can be simple or complex [<a href="#rid32">32,46,47</a>]. The classification may have localizing value. In a study of 20 patients, simple visual hallucinations localized to the occipital, occipitotemporal, and occipitoparietal regions of the cortex, while complex hallucinations localized to the occipitotemporal region and the temporal lobe [<a href="#rid46">46</a>]. Complex visual hallucinations did not occur in seizures restricted to the occipital lobe. (See  <a class="medical medical_review" href="/d/html/2231.html" rel="external">"Focal epilepsy: Causes and clinical features"</a>.)</p><p>Seizures arising from the occipital lobe are often associated with brightly colored circles or spherical patterns that may be multiplied or grow in size  (<a class="graphic graphic_figure graphicRef59850" href="/d/graphic/59850.html" rel="external">figure 2</a>) [<a href="#rid17">17,40,46-50</a>]. Motion is a frequent characteristic of epileptic hallucinations. The motion can be intrinsic to the hallucination, or the entire hallucination can move rapidly (usually in seconds) across the visual field in the direction contralateral to the seizure focus. Visual field deficits or blindness may also occur, and some patients also note visual illusions [<a href="#rid46">46,47,49,50</a>]. As with other epileptic phenomena, ictal visual hallucinations are usually stereotyped.</p><p>Epileptic hallucinations are binocular, usually occurring in one hemifield or the other; however, some patients misinterpret bilateral, homonymous visual field hallucinations as existing in only the ipsilateral eye. Insight in patients with epilepsy is typically, but not always, intact.</p><p>Epileptic hallucinations are usually brief, only a few seconds, unless the seizures are continuous [<a href="#rid40">40,47,48,50</a>]. The brief duration is especially true of idiopathic occipital epilepsy and is a differentiating feature from migraine hallucinations, which are longer in duration. The frequency is variable, but episodes tend to occur more frequently than do migraines; daily or weekly events are more common than less frequent occurrence [<a href="#rid47">47,50</a>]. Episodes are generally not provoked.</p><p>Although many visual seizures do not progress to other ictal manifestations, nearly all patients experience nonvisual epileptic symptoms at some time [<a href="#rid17">17,47,49-51</a>]. Some patients, initially misdiagnosed with migraine, eventually present with secondary generalized seizures [<a href="#rid29">29,47</a>]. Associated symptoms depend on the origin and spread of the seizure and can include déjà vu, somatosensory phenomena, head and eye deviation, motor activity, and/or impaired consciousness. Postictal headache is common in patients with occipital epilepsy and does not help to differentiate seizures from migrainous visual hallucinations [<a href="#rid47">47,50,51</a>].</p><p>For patients suspected of having seizures, a complete neurologic evaluation and an electroencephalogram (EEG) should be performed. An interictal EEG is abnormal in most, but not all, patients [<a href="#rid49">49</a>]. Neuroimaging is also indicated to look for etiologic structural brain disease. (See  <a class="medical medical_review" href="/d/html/2219.html" rel="external">"Evaluation and management of the first seizure in adults"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Neurodegenerative disease</span></p><p class="headingAnchor" id="H827708268"><span class="h3">Dementia with Lewy bodies and Parkinson disease</span><span class="headingEndMark"> — </span>Visual hallucinations are a core clinical feature of dementia with Lewy bodies (DLB) and are also common in Parkinson disease (PD) [<a href="#rid52">52-54</a>]. In DLB and PD, the hallucinations are characteristically complex, binocular, and occur throughout the entire visual field. Descriptions range from well-formed images of people or animals, to more abstract visions such as shapes or colors [<a href="#rid55">55</a>]. Insight may or may not be retained, depending in part on the degree of cognitive impairment. The content of the images may arouse fear or only indifference. Duration and frequency of the hallucinations are variable, but most last seconds to minutes and recur at least weekly [<a href="#rid55">55</a>].</p><p>In DLB, visual hallucinations occur in approximately two-thirds of patients and occur early in the disease course, often preceding the development of parkinsonism [<a href="#rid54">54</a>]. In addition to dementia, parkinsonism, visual hallucinations, and prominent fluctuations of cognition or alertness are characteristic of DLB. (See  <a class="medical medical_review" href="/d/html/5088.html" rel="external">"Clinical features and diagnosis of dementia with Lewy bodies"</a>.)</p><p>In PD, visual hallucinations are more prevalent later in the disease course. Dopaminergic medications can contribute substantively to their occurrence, as well as to other manifestations of psychosis in patients with PD. Discontinuation or dose-lowering of antiparkinson medications may alleviate these symptoms. Risk factors for visual hallucinations in PD include the use of high doses of antiparkinson drugs, dementia, advanced age, impaired vision, depression, and sleep disturbances [<a href="#rid52">52,56-58</a>]. (See  <a class="medical medical_review" href="/d/html/4903.html" rel="external">"Clinical manifestations of Parkinson disease", section on 'Psychotic symptoms'</a>.)</p><p>The treatment of visual hallucinations in these disorders is discussed separately. (See  <a class="medical medical_review" href="/d/html/5092.html" rel="external">"Prognosis and treatment of dementia with Lewy bodies"</a> and  <a class="medical medical_review" href="/d/html/4900.html" rel="external">"Management of nonmotor symptoms in Parkinson disease"</a>.)</p><p class="headingAnchor" id="H945821454"><span class="h3">Other dementia syndromes</span><span class="headingEndMark"> — </span>Visual hallucinations are relatively uncommon in Alzheimer disease (AD), particularly early in the disease course [<a href="#rid59">59,60</a>]. When present, these often reflect a superimposed delirium, medication effect, or vision loss [<a href="#rid53">53,61-65</a>] (see <a class="local">'Metabolic encephalopathy'</a> below). In patients with the relatively uncommon posterior cortical atrophy variant of AD, visual hallucinations are reported in up to 25 percent of patients [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/5071.html" rel="external">"Clinical features and diagnosis of Alzheimer disease", section on 'Atypical presentations'</a>.)</p><p>Visual hallucinations are also a rare, but reported, occurrence in frontotemporal dementia [<a href="#rid67">67-69</a>]. </p><p>Some patients with Creutzfeldt-Jakob disease (CJD) present with prominent visual symptoms that include visual perceptual difficulties and visual hallucinations [<a href="#rid70">70-73</a>]. These patients typically have a rapidly progressive dementia and myoclonus.</p><p class="headingAnchor" id="H10"><span class="h2">Alcohol and drug use or withdrawal</span><span class="headingEndMark"> — </span>Visual hallucinations can be a feature of drug and alcohol withdrawal syndromes, as well as intoxication with certain medications and drugs of abuse. The table lists the most common drugs associated with visual hallucinations  (<a class="graphic graphic_table graphicRef51079" href="/d/graphic/51079.html" rel="external">table 3</a>) [<a href="#rid74">74</a>]. The hallucinations can be simple or complex and can be monocular (in cases of drugs that affect the retina) or binocular.</p><p>Alcohol and benzodiazepine withdrawal usually produce complex hallucinations with vivid imagery [<a href="#rid32">32</a>]. These are often continuous and are associated with agitation, tremulousness, and autonomic hyperactivity. Hallucinations in other modalities can occur, and patients often appear to lack insight, interacting with the hallucinations. (See  <a class="medical medical_review" href="/d/html/323.html" rel="external">"Management of moderate and severe alcohol withdrawal syndromes"</a>.)</p><p>Most visual hallucinations caused by medications or recreational drug use are associated with acute intoxication. Hallucinations are usually complex, bilateral, and full field. There is usually associated confusion or frank delirium, often with auditory and tactile hallucinations. Many of these drugs are believed to produce these symptoms by their direct action on central neurotransmitter systems [<a href="#rid75">75</a>].</p><p>By contrast, <a class="drug drug_general" data-topicid="9360" href="/d/drug information/9360.html" rel="external">digoxin</a> and <a class="drug drug_general" data-topicid="9643" href="/d/drug information/9643.html" rel="external">sildenafil</a> can affect retinal function and produce simple hallucinations. Therapeutic, as well as toxic, levels of digoxin can produce simple hallucinations of black spots, dots of light, "television static," or a tint of yellow or green to the entire visual field [<a href="#rid76">76,77</a>]. When these visual hallucinations occur with digoxin use, level should be checked, and the dose of medication should be lowered or discontinued to prevent permanent retinal injury [<a href="#rid78">78</a>]. Visual hallucinations appear to be a dose-dependent side effect of sildenafil without known implications for long-term retinal injury [<a href="#rid79">79,80</a>].</p><p>Associated symptoms depend on the drug's side effect profile. As an example, anticholinergic drugs typically produce an agitated delirium, mydriasis, and urinary retention. (See  <a class="medical medical_review" href="/d/html/305.html" rel="external">"Anticholinergic poisoning"</a>.)</p><p>For most medication-induced hallucinations, dose-lowering or discontinuation of the drug may be necessary if the patient is intolerant of the hallucinations. For patients on dopaminergic therapy for whom dose reductions or discontinuation are not possible, treatment with an atypical antipsychotic or cholinesterase inhibitor can be considered [<a href="#rid81">81-83</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Peduncular hallucinosis</span><span class="headingEndMark"> — </span>Peduncular hallucinosis is a rare manifestation of lesions (usually stroke or neoplasm) affecting the midbrain, in particular, the paramedian reticular formation [<a href="#rid82">82-89</a>]. Similar syndromes have been described with pontine and thalamic lesions. The hallucinations are complex and binocular, involving both visual fields. The content of the complex imagery varies and is usually described as vivid and colorful. The hallucinations may have associated tactile and auditory content [<a href="#rid32">32,86,89</a>]. Insight is variably retained [<a href="#rid32">32,86,88-90</a>].</p><p>While some reports note a predilection for these to occur in the evening, this is not universal [<a href="#rid88">88,89</a>]. The duration is variable, ranging from a few minutes to a few hours. The frequency is also varied from just 1 to 2 episodes in all to 15 or more per day [<a href="#rid86">86,88</a>]. This is often a self-limited symptom that resolves spontaneously after a few weeks or months; however, symptoms can persist [<a href="#rid88">88-90</a>].</p><p>Associated symptoms include disturbances in the sleep-wake cycle, resulting in episodes of daytime somnolence and nighttime insomnia [<a href="#rid86">86,89</a>]. Other signs of brainstem and diencephalon dysfunction are often present, such as eye movement disturbances (vertical gaze palsies and saccadic pursuits), poor pupillary light reaction, ataxia, hemiparesis, and confusion. (See  <a class="medical medical_review" href="/d/html/1102.html" rel="external">"Posterior circulation cerebrovascular syndromes"</a>.)</p><p>The underlying mechanism for the hallucinations is uncertain. Some believe that the reticular activating system may be involved, while others invoke the role of the pontine-geniculate-occipital pathways [<a href="#rid86">86,89</a>]. Other data suggest that the subcortical regions implicated in peduncular hallucinosis share a specific functional connectivity, such that lesions in these areas might result in hyperactivity in extrastriate brain regions, which in turn might produce the expressed symptoms [<a href="#rid91">91</a>].</p><p>Neuroimaging is essential for patients suspected of having peduncular hallucinations. Antipsychotic agents have been effective in a few case reports [<a href="#rid86">86,92</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Narcolepsy</span><span class="headingEndMark"> — </span>The visual hallucinations of narcolepsy are complex, vivid, colored images, invariably occurring immediately before falling asleep (hypnagogic) or just after wakening (hypnopompic) [<a href="#rid93">93</a>]. Associated auditory or tactile sensations can occur. The duration and frequency are variable. Associated symptoms of narcolepsy include excessive daytime sleepiness, sleep paralysis, and cataplexy. Poor insight may occur because of the very realistic imagery, but most patients know the hallucinations are not real [<a href="#rid19">19,94</a>]. Even when insight is retained, fearful content can make patients dread sleep [<a href="#rid93">93</a>].</p><p>Hypnagogic and hypnopompic hallucinations are believed to result from intrusion of rapid eye movement (REM) sleep into wakefulness [<a href="#rid95">95</a>]. While a core feature of narcolepsy, community surveys report a high lifetime prevalence (up to 38 percent) of this phenomenon among individuals without narcolepsy [<a href="#rid32">32,96,97</a>]. Medications that disrupt sleep architecture (eg, serotonergic and anticholinergic antidepressants) can also produce hypnagogic and hypnopompic hallucinations [<a href="#rid98">98</a>]. Hypnagogic hallucinations associated with REM sleep abnormalities have also been described in Guillain-Barré syndrome (GBS) [<a href="#rid99">99</a>].</p><p>Diagnostic testing for narcolepsy includes an overnight polysomnogram followed by a multiple sleep latency test. (See  <a class="medical medical_review" href="/d/html/7689.html" rel="external">"Clinical features and diagnosis of narcolepsy in adults"</a>.)</p><p>While treatment in narcolepsy is usually focused on the more disabling symptoms of daytime sleepiness and cataplexy, hypnagogic hallucinations also often improve with these interventions. (See  <a class="medical medical_review" href="/d/html/7681.html" rel="external">"Treatment of narcolepsy in adults"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Psychiatric illness</span><span class="headingEndMark"> — </span>Most visual hallucinations in psychiatric illness are complex. Auditory hallucinations are approximately twice as common and typically accompany the visual hallucinations [<a href="#rid100">100,101</a>]. The content of the hallucinations is usually disturbing and antagonistic. Many, but not all, patients with psychiatric illness lack insight [<a href="#rid102">102</a>]. The duration and frequency of hallucinations are highly variable.</p><p>Symptoms of depression, mania, anxiety, disordered thoughts, or delusions are usually present. Delirium can accompany psychiatric illness as well, but if present, drug or alcohol use, metabolic encephalopathy, and other diagnoses should be considered. (See <a class="local">'Metabolic encephalopathy'</a> below and <a class="local">'Alcohol and drug use or withdrawal'</a> above.)</p><p>A complete psychiatric evaluation is essential for patients suspected of having hallucinations due to psychiatric illness. Antipsychotic medications are useful in treatment. (See  <a class="medical medical_review" href="/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Metabolic encephalopathy</span><span class="headingEndMark"> — </span>Visual hallucinations are a common feature of delirium, occurring in 27 percent of patients in one hospital series [<a href="#rid103">103</a>]. These patients are typically confused, often agitated, with other psychotic features including auditory or tactile hallucinations and delusions. In this form of "activated" delirium, etiologies are often multiple and can include central nervous system or systemic infection, hypoxia, medications, and metabolic disturbances, including hepatic or renal failure, electrolyte imbalance, and hypothyroidism [<a href="#rid104">104</a>]. (See  <a class="medical medical_review" href="/d/html/4824.html" rel="external">"Diagnosis of delirium and confusional states"</a>.)</p><p>A syndrome of agitated delirium, visual hallucinations, and hemianopia can also be produced by lesions (usually stroke) affecting the medial aspect of the occipital lobe, the parahippocampal gyrus, and hippocampus [<a href="#rid11">11</a>]. This can be difficult to distinguish from acute toxic metabolic encephalopathy.</p><p class="headingAnchor" id="H15"><span class="h2">Others</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Papilledema</strong> – Patients with papilledema may experience photopsias, simple visual hallucinations of lights, or brief visual obscurations [<a href="#rid105">105</a>]. These clear completely, are often unilateral, are typically very brief (just seconds), and are likely due to irritation of the retinal photoreceptor in the presence of significant edema of the retinal ganglion cell axons. (See  <a class="medical medical_review" href="/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5241.html" rel="external">"Overview and differential diagnosis of papilledema"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Optic neuritis</strong> – Simple visual hallucinations, often precipitated by eye movement, have also been reported in 30 percent of patients with optic neuritis and can occur in the absence of significant anterior optic nerve edema [<a href="#rid106">106</a>]. (See  <a class="medical medical_review" href="/d/html/5251.html" rel="external">"Optic neuritis: Pathophysiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reversible posterior leukoencephalopathy syndrome</strong> – Visual hallucinations along with visual field deficits and visual distortions can occur in the reversible posterior leukoencephalopathy syndrome, a phenomenon of reversible localized cerebral edema, often restricted to the occipital lobes, that occurs in patients with hypertension, renal failure, and/or immunosuppressive therapies [<a href="#rid107">107</a>]. Clinical features also include headache, altered consciousness, and seizures. Eclampsia and hypertensive encephalopathy are related conditions with similar symptoms. (See  <a class="medical medical_review" href="/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reversible cerebral vasoconstriction syndrome</strong> – While vision loss is a more frequent accompaniment to the sudden headache that is the clinical hallmark of this syndrome, visual hallucinations have been described in some cases [<a href="#rid108">108</a>]. (See  <a class="medical medical_review" href="/d/html/14075.html" rel="external">"Reversible cerebral vasoconstriction syndrome", section on 'Clinical presentation and course'</a>.)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>In many patients, the clinical setting (eg, patient with Parkinson disease [PD] or with longstanding vision loss) will identify the most likely cause of the visual hallucinations. In other cases, the clinical features suggest the more likely diagnoses and direct the diagnostic evaluation  (<a class="graphic graphic_table graphicRef73106" href="/d/graphic/73106.html" rel="external">table 1</a> and <a class="graphic graphic_algorithm graphicRef109600" href="/d/graphic/109600.html" rel="external">algorithm 1</a>). </p><p class="headingAnchor" id="H3809348537"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Visual hallucinations are under-reported by patients who fear that the hallucinations represent psychiatric disease or who lack insight into the unreal nature of the hallucinations [<a href="#rid1">1,9</a>]. Insight is an important feature that can distinguish among some etiologies.</p><p>The patient should be asked to describe their hallucinations. The characteristics of the hallucination, especially whether it is classified as simple or complex, help to determine the underlying cause  (<a class="graphic graphic_table graphicRef73106" href="/d/graphic/73106.html" rel="external">table 1</a>). (See <a class="local">'Classification and terminology'</a> above.)</p><p>In addition, clinicians should specifically inquire about the presence of other features, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Monocular versus binocular involvement</p><p class="bulletIndent1"><span class="glyph">●</span>Involved area of the visual field</p><p class="bulletIndent1"><span class="glyph">●</span>Motion, either intrinsic motion within the hallucination, or movement of the hallucination across the field of vision</p><p class="bulletIndent1"><span class="glyph">●</span>Triggers (eg, bright light, a dark room, or anxiety)</p><p class="bulletIndent1"><span class="glyph">●</span>Duration</p><p class="bulletIndent1"><span class="glyph">●</span>Frequency</p><p class="bulletIndent1"><span class="glyph">●</span>Insight that the visual perception is unreal</p><p class="bulletIndent1"><span class="glyph">●</span>Associated symptoms and medical history</p><p></p><p>Associated symptoms that can be relevant include vision loss, headache, impaired consciousness, confusion or memory loss, sensory or motor symptoms, gait difficulty, excessive daytime sleepiness, delusions, and hallucinations involving other senses. An alcohol, drug, and medication history should be taken in every case.</p><p class="headingAnchor" id="H3831534326"><span class="h2">Diagnostic testing</span><span class="headingEndMark"> — </span>All patients with new-onset visual hallucinations should have a complete neurologic evaluation with screening for cognitive impairment, parkinsonism, and other neurologic deficits. Medication lists should be reviewed for their potential contribution. Serum screening tests for alcohol and drugs of abuse may be useful for patients with unknown causes for hallucinations, particularly in the emergency department setting. An approach to diagnostic evaluation is presented in the algorithm and summarized briefly below  (<a class="graphic graphic_algorithm graphicRef109600" href="/d/graphic/109600.html" rel="external">algorithm 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>New onset of simple hallucinations that are monocular should have an urgent ophthalmologic examination.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the absence of neurologic abnormalities and in the setting of known ocular disease (eg, macular degeneration) the likely diagnosis is release hallucinations, and further diagnostic evaluation may not be required. (See  <a class="medical medical_review" href="/d/html/5250.html" rel="external">"Visual release hallucinations (Charles Bonnet syndrome)", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Simple hallucinations that meet criteria for migraine may not require further diagnostic evaluation (see <a class="local">'Migraine aura'</a> above). Atypical features include monocular symptoms and episodes that are atypically brief or prolonged.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Electroencephalography (EEG) is indicated when episodes are brief, frequent, and stereotyped; these features suggest seizure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If mental status examination is abnormal, evaluation for delirium, drug intoxication or withdrawal, or psychiatric disease is appropriate. (See  <a class="medical medical_review" href="/d/html/4824.html" rel="external">"Diagnosis of delirium and confusional states"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A brain magnetic resonance image is appropriate when hallucinations do not meet criteria for visual aura of migraine and when the neurologic examination is abnormal. Formal visual field testing can be useful to rule out subtle visual deficits not appreciated on gross examination. Some patients with acute occipital or temporal lobe infarct have visual hallucinations in the absence of a visual field defect by bedside examination [<a href="#rid109">109</a>]. </p><p></p><p class="headingAnchor" id="H100534427"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/85625.html" rel="external">"Patient education: Detached retina (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY</span><span class="headingEndMark"> — </span>A visual hallucination is the perception of an external visual stimulus where none exists.</p><p class="bulletIndent1"><span class="glyph">●</span>Simple visual hallucinations include images of unformed light, geometric shapes, or designs. Complex visual hallucinations are formed images of people, animals, or scenes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Etiologies of visual hallucinations include retinal disease, migraine, vision loss, neurodegenerative disease, alcohol and drug use, psychiatric illness, and toxic-metabolic encephalopathy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical features that help distinguish among etiologies are simple versus complex content, monocular versus binocular involvement, insight, and associated symptoms  (<a class="graphic graphic_table graphicRef73106" href="/d/graphic/73106.html" rel="external">table 1</a>). (See <a class="local">'Etiologies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical features direct the diagnostic evaluation  (<a class="graphic graphic_algorithm graphicRef109600" href="/d/graphic/109600.html" rel="external">algorithm 1</a>). New onset of simple hallucinations that are monocular should have an urgent ophthalmologic examination. In many other cases when the clinical setting suggests the most likely cause, diagnostic testing beyond ophthalmologic and neurologic examination may not be required. Neuroimaging, electroencephalography (EEG), and other tests are helpful in other cases. (See <a class="local">'Evaluation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol 2001; 131:590.</a></li><li><a class="nounderline abstract_t">Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusions. Semin Neurol 2000; 20:111.</a></li><li><a class="nounderline abstract_t">Wilkinson F. Auras and other hallucinations: windows on the visual brain. Prog Brain Res 2004; 144:305.</a></li><li><a class="nounderline abstract_t">Cogan DG. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1973; 188:139.</a></li><li><a class="nounderline abstract_t">Hikichi T, Yoshida A. Time course of development of posterior vitreous detachment in the fellow eye after development in the first eye. Ophthalmology 2004; 111:1705.</a></li><li><a class="nounderline abstract_t">Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol 2002; 134:329.</a></li><li><a class="nounderline abstract_t">Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 2003; 48:12.</a></li><li><a class="nounderline abstract_t">Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 2004; 4:5.</a></li><li><a class="nounderline abstract_t">Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347:794.</a></li><li><a class="nounderline abstract_t">Schultz G, Melzack R. The Charles Bonnet syndrome: 'phantom visual images'. Perception 1991; 20:809.</a></li><li><a class="nounderline abstract_t">Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996; 47:408.</a></li><li><a class="nounderline abstract_t">Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis 1998; 186:190.</a></li><li><a class="nounderline abstract_t">Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome. Surv Ophthalmol 2003; 48:58.</a></li><li><a class="nounderline abstract_t">Nesher R, Nesher G, Epstein E, Assia E. Charles Bonnet syndrome in glaucoma patients with low vision. J Glaucoma 2001; 10:396.</a></li><li><a class="nounderline abstract_t">Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995; 166:254.</a></li><li><a class="nounderline abstract_t">Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992; 149:1701.</a></li><li><a class="nounderline abstract_t">Kuzniecky R, Gilliam F, Morawetz R, et al. Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia 1997; 38:175.</a></li><li><a class="nounderline abstract_t">Lepore FE. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology 1990; 40:444.</a></li><li><a class="nounderline abstract_t">Szucs A, Janszky J, Holló A, et al. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand 2003; 108:314.</a></li><li><a class="nounderline abstract_t">Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: a review. J Nerv Ment Dis 1997; 185:195.</a></li><li><a class="nounderline abstract_t">Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992; 12:221.</a></li><li><a class="nounderline abstract_t">Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia 2004; 24:728.</a></li><li><a class="nounderline abstract_t">Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med 2002; 346:257.</a></li><li><a class="nounderline abstract_t">Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke 1998; 29:1539.</a></li><li><a class="nounderline abstract_t">Rasmussen BK, Jensen R, Olesen J. A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991; 11:129.</a></li><li><a class="nounderline abstract_t">SELBY G, LANCE JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23:23.</a></li><li><a class="nounderline abstract_t">James MF, Smith JM, Boniface SJ, et al. Cortical spreading depression and migraine: new insights from imaging? Trends Neurosci 2001; 24:266.</a></li><li><a class="nounderline abstract_t">Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119 ( Pt 2):355.</a></li><li><a class="nounderline abstract_t">Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry 1994; 57:1371.</a></li><li><a class="nounderline abstract_t">Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology 1973; 23:570.</a></li><li><a class="nounderline abstract_t">Queiroz LP, Rapoport AM, Weeks RE, et al. Characteristics of migraine visual aura. Headache 1997; 37:137.</a></li><li><a class="nounderline abstract_t">Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121 ( Pt 10):1819.</a></li><li><a class="nounderline abstract_t">Evans RW, Daroff RB. Expert opinion: monocular visual aura with headache: retinal migraine? Headache 2000; 40:603.</a></li><li><a class="nounderline abstract_t">Mattsson P, Lundberg PO. Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura. Cephalalgia 1999; 19:479.</a></li><li><a class="nounderline abstract_t">Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 Suppl 7:1.</a></li><li><a class="nounderline abstract_t">Liu GT, Schatz NJ, Galetta SL, et al. Persistent positive visual phenomena in migraine. Neurology 1995; 45:664.</a></li><li><a class="nounderline abstract_t">Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48:261.</a></li><li><a class="nounderline abstract_t">Haas DC. Prolonged migraine aura status. Ann Neurol 1982; 11:197.</a></li><li><a class="nounderline abstract_t">Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001; 41:823.</a></li><li><a class="nounderline abstract_t">Menon B. Symptomatic occipital epilepsy misdiagnosed as migraine. Headache 2007; 47:287.</a></li><li><a class="nounderline abstract_t">Eriksen MK, Thomsen LL, Olesen J. The Visual Aura Rating Scale (VARS) for migraine aura diagnosis. Cephalalgia 2005; 25:801.</a></li><li><a class="nounderline abstract_t">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.</a></li><li><a class="nounderline abstract_t">Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000; 55:1588.</a></li><li><a class="nounderline abstract_t">San-Juan OD, Zermeño PF. Migraine with persistent aura in a Mexican patient: case report and review of the literature. Cephalalgia 2007; 27:456.</a></li><li><a class="nounderline abstract_t">Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979; 10:299.</a></li><li><a class="nounderline abstract_t">Bien CG, Benninger FO, Urbach H, et al. Localizing value of epileptic visual auras. Brain 2000; 123 ( Pt 2):244.</a></li><li><a class="nounderline abstract_t">Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry 1999; 66:536.</a></li><li><a class="nounderline abstract_t">Kawai M, Cherches IM, Goldsmith IL. Visual illusory and hallucinatory phenomena in a patient with left occipital seizures. Neurology 2006; 67:1457.</a></li><li><a class="nounderline abstract_t">Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy. Brain 1992; 115 ( Pt 6):1655.</a></li><li><a class="nounderline abstract_t">Panayiotopoulos CP. Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine. Epileptic Disord 1999; 1:205.</a></li><li><a class="nounderline abstract_t">Andermann F, Zifkin B. The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine. Epilepsia 1998; 39 Suppl 4:S9.</a></li><li><a class="nounderline abstract_t">Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53:1265.</a></li><li><a class="nounderline abstract_t">Assal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 2002; 15:445.</a></li><li><a class="nounderline abstract_t">McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017; 89:88.</a></li><li><a class="nounderline abstract_t">Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001; 70:727.</a></li><li><a class="nounderline abstract_t">Manni R, Pacchetti C, Terzaghi M, et al. Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 2002; 59:1979.</a></li><li><a class="nounderline abstract_t">Kulisevsky J, Roldan E. Hallucinations and sleep disturbances in Parkinson's disease. Neurology 2004; 63:S28.</a></li><li><a class="nounderline abstract_t">Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70:734.</a></li><li><a class="nounderline abstract_t">Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 2006; 129:729.</a></li><li><a class="nounderline abstract_t">Sinforiani E, Terzaghi M, Pasotti C, et al. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients. Neurol Sci 2007; 28:96.</a></li><li><a class="nounderline abstract_t">Murgatroyd C, Prettyman R. An investigation of visual hallucinosis and visual sensory status in dementia. Int J Geriatr Psychiatry 2001; 16:709.</a></li><li><a class="nounderline abstract_t">Monastero R, Camarda C, Pipia C, Camarda R. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases. J Neurol Neurosurg Psychiatry 2007; 78:546.</a></li><li><a class="nounderline abstract_t">Terao T. Visual hallucinations in Alzheimer's disease: possible involvement of low visual acuity and dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2000; 12:516.</a></li><li><a class="nounderline abstract_t">Gareri P, De Fazio P, Cotroneo A, et al. Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. Arch Gerontol Geriatr 2007; 44 Suppl 1:199.</a></li><li><a class="nounderline abstract_t">Chapman FM, Dickinson J, McKeith I, Ballard C. Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry 1999; 156:1983.</a></li><li><a class="nounderline abstract_t">Josephs KA, Whitwell JL, Boeve BF, et al. Visual hallucinations in posterior cortical atrophy. Arch Neurol 2006; 63:1427.</a></li><li><a class="nounderline abstract_t">Landqvist Waldö M, Gustafson L, Passant U, Englund E. Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma? Int Psychogeriatr 2015; 27:531.</a></li><li><a class="nounderline abstract_t">Chan D, Anderson V, Pijnenburg Y, et al. The clinical profile of right temporal lobe atrophy. Brain 2009; 132:1287.</a></li><li><a class="nounderline abstract_t">Omar R, Sampson EL, Loy CT, et al. Delusions in frontotemporal lobar degeneration. J Neurol 2009; 256:600.</a></li><li><a class="nounderline abstract_t">Taratuto AL, Piccardo P, Reich EG, et al. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology 2002; 58:362.</a></li><li><a class="nounderline abstract_t">Armstrong RA. Creutzfeldt-Jakob disease and vision. Clin Exp Optom 2006; 89:3.</a></li><li><a class="nounderline abstract_t">Pachalska M, Kurzbauer H, MacQueen BD, et al. Neuropsychological features of rapidly progressive dementia in a patient with an atypical presentation of Creutzfeldt-Jakob Disease. Med Sci Monit 2001; 7:1307.</a></li><li><a class="nounderline abstract_t">Gooriah R, Dafalla BE, Tun S, et al. Visual hallucinations: an unusual manifestation of sporadic Creutzfeldt-Jakob disease termed the 'Heidenhain variant'. J Neurol 2014; 261:2228.</a></li><li class="breakAll">Liu GL, Volpe NJ, Galetta SL. Visual Hallucinations and Illusions. In: Neuro-Ophthalmology: Diagnosis and Management, 2nd ed, Liu GL, Volpe NJ, Galetta SL, (Eds), Saunders, 2010. p.393.</li><li><a class="nounderline abstract_t">Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005; 28:737.</a></li><li><a class="nounderline abstract_t">Piltz JR, Wertenbaker C, Lance SE, et al. Digoxin toxicity. Recognizing the varied visual presentations. J Clin Neuroophthalmol 1993; 13:275.</a></li><li><a class="nounderline abstract_t">Butler VP Jr, Odel JG, Rath E, et al. Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations. Ann Intern Med 1995; 123:676.</a></li><li><a class="nounderline abstract_t">Wolin MJ. Digoxin visual toxicity with therapeutic blood levels of digoxin. Am J Ophthalmol 1998; 125:406.</a></li><li><a class="nounderline abstract_t">Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3:12.</a></li><li><a class="nounderline abstract_t">Dündar SO, Topalo Gcaron Lu A, Dündar M, Koçak I. Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use. Eye (Lond) 2006; 20:810.</a></li><li><a class="nounderline abstract_t">Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39.</a></li><li><a class="nounderline abstract_t">Dunn DW, Weisberg LA, Nadell J. Peduncular hallucinations caused by brainstem compression. Neurology 1983; 33:1360.</a></li><li><a class="nounderline abstract_t">Maiuri F, Iaconetta G, Sardo L, Buonamassa S. Peduncular hallucinations associated with large posterior fossa meningiomas. Clin Neurol Neurosurg 2002; 104:41.</a></li><li><a class="nounderline abstract_t">Lhermitte J. Syndrome de la calotte pédonculaire. Les troubles psychosensorielles dans les lésions du mésencéphale. Rev Neurol 1922; :1359.</a></li><li><a class="nounderline abstract_t">Caplan LR. "Top of the basilar" syndrome. Neurology 1980; 30:72.</a></li><li><a class="nounderline abstract_t">Kölmel HW. Peduncular hallucinations. J Neurol 1991; 238:457.</a></li><li><a class="nounderline abstract_t">Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol 1987; 21:602.</a></li><li><a class="nounderline abstract_t">Roser F, Ritz R, Koerbel A, et al. Peduncular hallucinosis: insights from a neurosurgical point of view. Neurosurgery 2005; 57:E1068; discussion E1068.</a></li><li><a class="nounderline abstract_t">Benke T. Peduncular hallucinosis: a syndrome of impaired reality monitoring. J Neurol 2006; 253:1561.</a></li><li><a class="nounderline abstract_t">Kamalakannan D, Ravi S, Moudgil SS. Peduncular hallucinosis: unusual complication of cardiac catheterization. South Med J 2004; 97:999.</a></li><li><a class="nounderline abstract_t">Boes AD, Prasad S, Liu H, et al. Network localization of neurological symptoms from focal brain lesions. Brain 2015; 138:3061.</a></li><li><a class="nounderline abstract_t">O'Neill SB, Pentland B, Sellar R. Peduncular hallucinations following subarachnoid haemorrhage. Br J Neurosurg 2005; 19:359.</a></li><li><a class="nounderline abstract_t">Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003; 114:2000.</a></li><li><a class="nounderline abstract_t">Feldman NT. Narcolepsy. South Med J 2003; 96:277.</a></li><li><a class="nounderline abstract_t">Bódizs R, Sverteczki M, Lázár AS, Halász P. Human parahippocampal activity: non-REM and REM elements in wake-sleep transition. Brain Res Bull 2005; 65:169.</a></li><li><a class="nounderline abstract_t">Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169:459.</a></li><li><a class="nounderline abstract_t">Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000; 97:153.</a></li><li><a class="nounderline abstract_t">Cancelli I, Marcon G, Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol 2004; 19:577.</a></li><li><a class="nounderline abstract_t">Cochen V, Arnulf I, Demeret S, et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain 2005; 128:2535.</a></li><li><a class="nounderline abstract_t">Bowman KM, Raymond AF. A statistical study in the manic-depressive psychoses. Am J Psychiatry 1931; 88:299.</a></li><li><a class="nounderline abstract_t">Black DW, Nasrallah A. Hallucinations and delusions in 1,715 patients with unipolar and bipolar affective disorders. Psychopathology 1989; 22:28.</a></li><li><a class="nounderline abstract_t">Goodwin DW, Alderson P, Rosenthal R. Clinical significance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients. Arch Gen Psychiatry 1971; 24:76.</a></li><li><a class="nounderline abstract_t">Webster R, Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics 2000; 41:519.</a></li><li><a class="nounderline abstract_t">Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry 2004; 75:362.</a></li><li><a class="nounderline abstract_t">Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984; 16:489.</a></li><li><a class="nounderline abstract_t">The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991; 109:1673.</a></li><li><a class="nounderline abstract_t">Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.</a></li><li><a class="nounderline abstract_t">Yagi Y, Watanabe Y, Yokote H, et al. Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome. Neurol Sci 2013; 34:1023.</a></li><li><a class="nounderline abstract_t">Winton-Brown TT, Ting A, Mocellin R, et al. Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations. AJNR Am J Neuroradiol 2016; 37:774.</a></li></ol></div><div id="topicVersionRevision">Topic 5255 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11336933" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Visual hallucinations in patients with retinal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10874781" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Visual perceptual abnormalities: hallucinations and illusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14650857" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Auras and other hallucinations: windows on the visual brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4543235" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Visual hallucinations as release phenomena.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15350326" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Time course of development of posterior vitreous detachment in the fellow eye after development in the first eye.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12208243" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Acute zonal occult outer retinopathy: a long-term follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559325" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Paraneoplastic retinopathies and optic neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15180904" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8622335" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1816537" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The Charles Bonnet syndrome: 'phantom visual images'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8757013" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9521356" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Risk indicators for the Charles Bonnet syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559327" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711837" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Charles Bonnet syndrome in glaucoma patients with low vision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7728372" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1443247" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Visual hallucinations in patients with macular degeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9048669" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2314586" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12956834" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Misleading hallucinations in unrecognized narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9091601" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The Charles Bonnet syndrome: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1525797" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Migraine with aura and migraine without aura: an epidemiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15315528" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The aura: a tertiary care study of 952 migraine patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11807151" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Migraine--current understanding and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9707189" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Migrainous visual accompaniments are not rare in late life: the Framingham Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1889068" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A population-based analysis of the diagnostic criteria of the International Headache Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14444681" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Observations on 500 cases of migraine and allied vascular headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11311378" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cortical spreading depression and migraine: new insights from imaging?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8800932" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A nosographic analysis of the migraine aura in a general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7964814" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Elementary visual hallucinations in migraine and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4736304" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Visual symptoms in the migraine syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9100397" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Characteristics of migraine visual aura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9798740" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Complex visual hallucinations. Clinical and neurobiological insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10940102" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Expert opinion: monocular visual aura with headache: retinal migraine?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10403062" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3048700" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7723952" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Persistent positive visual phenomena in migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9008529" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Successful treatment of persistent migraine aura with divalproex sodium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7073253" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prolonged migraine aura status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11576209" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Persistent migrainous visual phenomena might be responsive to lamotrigine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17300372" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Symptomatic occipital epilepsy misdiagnosed as migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16162257" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The Visual Aura Rating Scale (VARS) for migraine aura diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11094126" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Acetazolamide treatment for migraine aura status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17388804" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Migraine with persistent aura in a Mexican patient: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/462518" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Isoproterenol treatment of visual symptoms in migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10648433" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Localizing value of epileptic visual auras.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201433" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17060573" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Visual illusory and hallucinatory phenomena in a patient with left occipital seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1486456" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10937155" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9637589" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8970453" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Visual hallucinations associated with Parkinson disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12151841" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Neuropsychiatric symptoms in the dementias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28592453" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11385004" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Visual hallucinations in Parkinson's disease: a review and phenomenological survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12499497" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15505140" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Hallucinations and sleep disturbances in Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11385005" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prospective study of hallucinations and delusions in Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16401618" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17464473" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11466750" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : An investigation of visual hallucinosis and visual sensory status in dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030587" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11083173" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Visual hallucinations in Alzheimer's disease: possible involvement of low visual acuity and dementia with Lewy bodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17317453" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10588415" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17030659" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Visual hallucinations in posterior cortical atrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25486967" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19297506" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The clinical profile of right temporal lobe atrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19365594" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Delusions in frontotemporal lobar degeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11839833" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16430434" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Creutzfeldt-Jakob disease and vision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11687748" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Neuropsychological features of rapidly progressive dementia in a patient with an atypical presentation of Creutzfeldt-Jakob Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287018" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Visual hallucinations: an unusual manifestation of sporadic Creutzfeldt-Jakob disease termed the 'Heidenhain variant'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287018" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Visual hallucinations: an unusual manifestation of sporadic Creutzfeldt-Jakob disease termed the 'Heidenhain variant'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16372931" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8113441" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Digoxin toxicity. Recognizing the varied visual presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7574223" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Digitalis-induced visual disturbances with therapeutic serum digitalis concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9512168" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Digoxin visual toxicity with therapeutic blood levels of digoxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16409214" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052253" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10615891" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Hypocretin (orexin) deficiency in human narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6684235" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Peduncular hallucinations caused by brainstem compression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11792475" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Peduncular hallucinations associated with large posterior fossa meningiomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Syndrome de la calotte pédonculaire. Les troubles psychosensorielles dans les lésions du mésencéphale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7188637" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : "Top of the basilar" syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1779254" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Peduncular hallucinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3606047" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16284548" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Peduncular hallucinosis: insights from a neurosurgical point of view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17006630" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Peduncular hallucinosis: a syndrome of impaired reality monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15558929" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Peduncular hallucinosis: unusual complication of cardiac catheterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26264514" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Network localization of neurological symptoms from focal brain lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16455547" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Peduncular hallucinations following subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14580598" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Clinical aspects and pathophysiology of narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12659360" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15763184" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Human parahippocampal activity: non-REM and REM elements in wake-sleep transition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8894197" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Hypnagogic and hypnopompic hallucinations: pathological phenomena?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11166087" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Prevalence of hallucinations and their pathological associations in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15495200" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Factors associated with complex visual hallucinations during antidepressant treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16000335" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barrésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : A statistical study in the manic-depressive psychoses</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2657835" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Hallucinations and delusions in 1,715 patients with unipolar and bipolar affective disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5538855" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Clinical significance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11110116" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Prevalence of psychotic symptoms in delirium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14966146" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Delirium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6497356" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Transient visual obscurations with elevated optic discs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1841573" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8559202" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : A reversible posterior leukoencephalopathy syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22843246" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26744445" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
